Skip to Content

SHIRE 465 12.5 mg (Mydayis 12.5 mg)

Generic Name: amphetamine/dextroamphetamine

Pill with imprint SHIRE 465 12.5 mg is Green, Capsule-shape and has been identified as Mydayis 12.5 mg. It is supplied by Shire US, Inc..

Mydayis is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Mydayis 12.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for SHIRE 465 12.5 mg

Mydayis 12.5 mg SHIRE 465 12.5 mg

Mydayis

Generic Name
amphetamine/dextroamphetamine
Imprint
SHIRE 465 12.5 mg
Strength
12.5 mg
Color
Green
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Shire US, Inc.
National Drug Code (NDC)
54092-0468
Inactive Ingredients
methacrylic acid - ethyl acrylate copolymer (1:1) type a, sucrose, magnesium silicate, triethyl citrate, FD&C Blue No. 2, ferric oxide yellow, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.